456 Views
Category: HIV: Treatment
Poster Session: HIV: Treatment
Christine L. Talarico
Clinical Virologist
ViiV Healthcare
Research Triangle Park, North Carolina
Disclosure: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
Sterling Wu
Statistics Leader
GlaxoSmithKline
Collegeville, Pennsylvania
Disclosure: GlaxoSmithKline (Employee, Shareholder)
Ojesh R. Upadhyay
Sr. Programming Manager
GlaxoSmithKline
Phoenixville, Pennsylvania
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Marty St. Clair
Ms
ViiV Healthcare
Research Triangle Park, NC
Disclosure: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
Veerle Van Eygen
Senior Scientist
Janssen Pharmaceutica NV
Beerse, Antwerpen, Belgium
Disclosure: Janssen Pharmaceutica NV (Employee)
Krischan J. Hudson
Director of Clinical Development
ViiV Healthcare
Research Triangle Park, NC
Disclosure: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
Sandy Griffith
Director Clinical Development
ViiV Healthcare
Research Triangle Park, NC
Disclosure: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
Conn M. Harrington
Clinical Investigation Lead
ViiV Healthcare
Research Triangle Park, NC
Disclosure: ViiV Healthcare (Employee)
Jan van Lunzen
Head of Translational Medicine
ViiV Healthcare
London, England, United Kingdom
Disclosure: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
David Margolis
Director of HIV Drug Development
ViiV Healthcare
Research Triangle Park, North Carolina
Disclosure: GlaxoSmithKline (Shareholder)ViiV Healthcare (Employee)
William Spreen
R&D, Medicine Development Leader
ViiV Healthcare
Research Triangle Park, North Carolina
Disclosure: ViiV Healthcare (Employee, Shareholder)